Clinical trial
CFTR Modulators and Gastrointestinal Complications
NCT05253859 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CFTR Modulators and Gastrointestinal Complications
- Lead sponsor
- Nottingham University Hospitals NHS Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2021
- Completion date
- February 10, 2024
- Enrollment
- 47,023 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis, digestive system disease, distal intestinal obstruction syndrome, gastrointestinal system disease, lung diseases, pancreatic disease, pancreatic enzyme abnormality